NYSE:PBYI

Puma Biotechnology Stock Insider Trading

etoro logo Buy PBYI
*Your capital is at risk
$6.81
-0.170 (-2.44%)
At Close: Jun 03, 2026

Puma Biotechnology Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -28.94. In total, the insiders bought 2.83M and sold 746K PBYI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-28.94
Buy 2.83M shares
Sell 746K shares
41% Buy Activity
Moderate Positive Correlation
Buy Signal Low Confidence
Feb 18, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -28.94.
  • Partially supported by a positive historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Feb 18, 2026
Buy
Stock Option (Right to Buy)
A-Award
Nougues Maximo F
Chief Financial Officer
C-Suite Officer 66 541
Value: $444.5K
Feb 18, 2026
Buy
Stock Option (Right to Buy)
A-Award
Hunt Douglas M
See Remarks
Officer 70 321
Value: $469.7K
Feb 18, 2026
Buy
Common Stock
A-Award
Hunt Douglas M
See Remarks
Officer 49 394
Value: $330.0K
Feb 18, 2026
Buy
Stock Option (Right to Buy)
A-Award
Auerbach Alan H
President And CEO
CEO / President 227 474
Value: $1.52M
Feb 18, 2026
Buy
Common Stock
A-Award
Auerbach Alan H
President And CEO
CEO / President 159 778
Value: $1.07M
Feb 18, 2026
Buy
Common Stock
A-Award
Nougues Maximo F
Chief Financial Officer
C-Suite Officer 46 739
Value: $312.2K
Jan 07, 2026
Sell
Common Stock
S-Sale
Nougues Maximo F
Chief Financial Officer
C-Suite Officer 6 405
Value: $37.7K
Jan 07, 2026
Sell
Common Stock
S-Sale
Auerbach Alan H
President And CEO
CEO / President 18 012
Value: $105.9K
Jan 07, 2026
Sell
Common Stock
S-Sale
Hunt Douglas M
See Remarks
Officer 5 014
Value: $29.5K
Jan 06, 2026
Sell
Common Stock
S-Sale
Nougues Maximo F
Chief Financial Officer
C-Suite Officer 4 540
Value: $26.5K
Jan 06, 2026
Sell
Common Stock
S-Sale
Auerbach Alan H
President And CEO
CEO / President 16 938
Value: $99.0K
Jan 06, 2026
Sell
Common Stock
S-Sale
Hunt Douglas M
See Remarks
Officer 3 973
Value: $23.2K
Nov 11, 2025
Sell
Common Stock
S-Sale
Miller Michael Patrick
Director
Director 20 000
Value: $97.2K
Jul 18, 2025
Sell
Common Stock
S-Sale
Cesano Alessandra
Director
Director 27 000
Value: $90.9K
Jul 18, 2025
Sell
Common Stock
S-Sale
Cesano Alessandra
Director
Director 27 000
Value: $90.9K
Jul 09, 2025
Sell
Common Stock
S-Sale
Nougues Maximo F
Chief Financial Officer
C-Suite Officer 3 935
Value: $13.9K
Jul 09, 2025
Sell
Common Stock
S-Sale
Hunt Douglas M
See Remarks
Officer 3 443
Value: $12.2K
Jul 09, 2025
Sell
Common Stock
S-Sale
Auerbach Alan H
President And CEO
CEO / President 21 580
Value: $76.3K
Jul 09, 2025
Sell
Common Stock
S-Sale
Auerbach Alan H
President And CEO
CEO / President 21 580
Value: $76.3K
Jul 09, 2025
Sell
Common Stock
S-Sale
Hunt Douglas M
See Remarks
Officer 3 443
Value: $12.2K
Jul 09, 2025
Sell
Common Stock
S-Sale
Nougues Maximo F
Chief Financial Officer
C-Suite Officer 3 935
Value: $13.9K
Jul 08, 2025
Sell
Common Stock
S-Sale
Nougues Maximo F
Chief Financial Officer
C-Suite Officer 5 587
Value: $19.7K
Jul 08, 2025
Sell
Common Stock
S-Sale
Hunt Douglas M
See Remarks
Officer 4 374
Value: $15.5K
Jul 08, 2025
Sell
Common Stock
S-Sale
Auerbach Alan H
President And CEO
CEO / President 25 592
Value: $90.4K
Jul 08, 2025
Sell
Common Stock
S-Sale
Auerbach Alan H
President And CEO
CEO / President 25 592
Value: $90.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PUMA BIOTECHNOLOGY INC
Puma Biotechnology
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advance...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE